These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24289957)

  • 1. A case of fulminant neuromyelitis optica presenting with destructive lesions in whole-brain.
    Sugiyama A; Ito S; Hirano S; Mori M; Kuwabara S
    Clin Neurol Neurosurg; 2014 Jan; 116():87-9. PubMed ID: 24289957
    [No Abstract]   [Full Text] [Related]  

  • 2. "Cloud-like enhancement" is a magnetic resonance imaging abnormality specific to neuromyelitis optica.
    Ito S; Mori M; Makino T; Hayakawa S; Kuwabara S
    Ann Neurol; 2009 Sep; 66(3):425-8. PubMed ID: 19798642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central nervous system aquaporin-4 autoimmunity presenting with an isolated cerebral abnormality.
    Kim SH; Kim W; Kook MC; Hong EK; Kim HJ
    Mult Scler; 2012 Sep; 18(9):1340-3. PubMed ID: 22760103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The spectrum of neuromyelitis optica.
    Wingerchuk DM; Lennon VA; Lucchinetti CF; Pittock SJ; Weinshenker BG
    Lancet Neurol; 2007 Sep; 6(9):805-15. PubMed ID: 17706564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central nervous system Aquaporin4 autoimmunity revealed by a single pseudotumoral encephalic lesion.
    Fargeot G; Aboab J; Savatovsky J; Marignier R; Lecler A; Gout O
    Metab Brain Dis; 2018 Feb; 33(1):353-355. PubMed ID: 29090380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intractable vomiting as the initial presentation of neuromyelitis optica.
    Apiwattanakul M; Popescu BF; Matiello M; Weinshenker BG; Lucchinetti CF; Lennon VA; McKeon A; Carpenter AF; Miller GM; Pittock SJ
    Ann Neurol; 2010 Nov; 68(5):757-61. PubMed ID: 21031587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromyelitis optica without typical opticospinal phenotype.
    Sato D; Fujihara K
    Mult Scler; 2010 Oct; 16(10):1154-5. PubMed ID: 20884688
    [No Abstract]   [Full Text] [Related]  

  • 8. A case of neuromyelitis optica with gadolinium-enhancing brain lesions and Parinaud syndrome.
    Gilmore CP; Jacob A; Evangelou N
    Arch Neurol; 2009 Jan; 66(1):140; author reply 140-1. PubMed ID: 19139317
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.
    Pittock SJ; Weinshenker BG; Lucchinetti CF; Wingerchuk DM; Corboy JR; Lennon VA
    Arch Neurol; 2006 Jul; 63(7):964-8. PubMed ID: 16831965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent insights into the pathology of multiple sclerosis and neuromyelitis optica.
    Wegner C
    Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S38-41. PubMed ID: 24321153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromyelitis optica and anti-aquaporin-4 antibodies: widening the clinical phenotype.
    Giovannoni G
    J Neurol Neurosurg Psychiatry; 2006 Sep; 77(9):1001-2. PubMed ID: 16709582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromyelitis optica-like pathology is dependent on type I interferon response.
    Khorooshi R; Wlodarczyk A; Asgari N; Owens T
    Exp Neurol; 2013 Sep; 247():744-7. PubMed ID: 23434493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meningoencephalitis as an initial manifestation of neuromyelitis optica spectrum disorder.
    Wang JY; Wang K; Chen XW; Wang JW; Zhang K; Xu MW; Luo BY
    Mult Scler; 2013 Apr; 19(5):639-43. PubMed ID: 23069875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supraspinal demyelinating lesions in neuromyelitis optica display a typical astrocyte pathology.
    Lee DH; Metz I; Berthele A; Stadelmann C; Brück W; Linker RA; Gold R; Schroeder A
    Neuropathol Appl Neurobiol; 2010 Dec; 36(7):685-7. PubMed ID: 20618839
    [No Abstract]   [Full Text] [Related]  

  • 15. Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity.
    Kim W; Park MS; Lee SH; Kim SH; Jung IJ; Takahashi T; Misu T; Fujihara K; Kim HJ
    Mult Scler; 2010 Oct; 16(10):1229-36. PubMed ID: 20685766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuromyelitis optica].
    Kvistad SA; Wergeland S; Torkildsen Ø; Myhr KM; Vedeler CA
    Tidsskr Nor Laegeforen; 2013 Oct; 133(19):2057-61. PubMed ID: 24129537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myasthenia gravis-associated neuromyelitis optica-like disease: an immunological link between the central nervous system and muscle?
    Vaknin-Dembinsky A; Abramsky O; Petrou P; Ben-Hur T; Gotkine M; Brill L; Brenner T; Argov Z; Karussis D
    Arch Neurol; 2011 Dec; 68(12):1557-61. PubMed ID: 21825214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain MRI abnormalities in neuromyelitis optica.
    Wang F; Liu Y; Duan Y; Li K
    Eur J Radiol; 2011 Nov; 80(2):445-9. PubMed ID: 20884147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosing neuromyelitis optica.
    Makhani N; Bigi S; Banwell B; Shroff M
    Neuroimaging Clin N Am; 2013 May; 23(2):279-91. PubMed ID: 23608690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evolving mystery of why skeletal muscle is spared in seropositive neuromyelitis optica.
    Verkman AS; Yao X; Smith AJ
    J Cell Mol Med; 2018 Mar; 22(3):2039-2040. PubMed ID: 29363875
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.